Wen Daxiang, and his delegation visited AVT for investigation

On March 23, 2020, Wen Daxiang, director of the Municipal Supervision Bureau, Li Jie, director of the drug registration office, Shi Lan, director of the drug regulatory office and other relevant department personnel came to AVT for investigation.

On behalf of the company, Dr. Cao Liang, general manager, extended a warm welcome to the research team and introduced in detail the overall situation and main business contents of AVT. This paper made in-depth exchanges on the development and planning of AVT at this stage, and sought guidance from the research team.

Director Wen spoke highly of and fully affirmed the development of AVT, and encouraged us to keep on developing. As a pharmaceutical auxiliary material enterprise, AVT paid close attention to the industry trends in time, especially various laws and regulations, such as the draft for opinions on drug registration management measures, and put forward enterprise opinions to promote the development of the industry.

Wen said that as a regulatory body, the Shanghai drug administration is trying to provide favorable help for the development of enterprises.